Oncology Nutrition Market Analysis | global Industry Forecast 2019-2026

Upcoming

2023

Oncology Nutrition Market

by Type (Head Neck Cancer, Stomach Gastrointestinal Cancers, Esophageal Cancer, Pancreatic Cancer, Liver Cancer, Blood Cancer, Breast Cancer, Lung Cancer, Other cancers): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals	Report Code: A05116	Nov 2023 \| Pages: NA
Tables: NA	Charts: NA	Formats*: Single User License, Five User License & Enterprise User License Data Pack Excel License It comes with the additional cost of $2500.00 contact sales.

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Oncology Nutrition Market

Request Now !

Cancer involves uncontrollable growth of abnormal cells. These cells are called as tumor cells or malignant cells. The field of medication that deals with the avoidance, treatment, and analysis of cancer is known as oncology. Oncology nutrition is termed as nutrition and diet for a cancer patient either during treatment or after the treatment. Nutrition plays a significant role in several aspects of cancer development and is an important helpful therapy during cancer treatment. Adequate nutrition provision can help cancer patients to maintain weight and slim body composition, offering improved recovery, and better quality of life. Right nutrition for a patient suffering from cancer delivers strength to fight with the illness. The correct food helps the patient endure the distressing effects of cancer and its treatment. Good nutrition also provides more energy and improves the quality of life by dealing with side effects of treatment and helps in speeding the recovery of the patient. Furthermore, it also helps in healing wounds after chemotherapy, radiotherapy, surgery, or other treatment.

Development of elemental formulas and launch of new products for nutrition of oncology patients, rise in prevalence of cancer, increase in focus on enteral nutrition, surge in demand for nutritional food from the homecare sector are expected to drive the oncology nutrition market in the coming years. Moreover, rise in clinical research on nutritional interventions, and increase in awareness for nutrition of cancer patients are expected to boost the oncology nutrition market during the forecast period. However, tube feeding-related complications and restricted reimbursement associated with its use are the major restraints that can hamper the growth of the market. In addition, rapid product origination and improvement of elemental formulas in the field are expected to provide numerous opportunities for the oncology nutrition market in the coming years.

The oncology nutrition market is segmented based on type of cancer, and region. Based on type of cancer, the market is categorized into head & neck cancer, stomach and gastrointestinal cancers, esophageal cancer, pancreatic cancer, liver cancer, blood cancer, breast cancer, and other cancers. The neck and head segment accounted for an important share of the oncology nutrition market. Neck and head cancer patients suffer from chronic problems associated to oral nutritional consumption through enteral route for nutrition support. The use of tube nurturing formulas has experienced growth with an increase in the number of cancer cases. The neck and head cancer reports for around 4% of all cancers in the U.S. American Society of Clinical Oncology (ASCO), in 2017, reported that 64,690 people (17,040 women and 47,650 men) developed neck and head cancer in 2017. Based on region, the oncology nutrition market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major players operating in the oncology nutrition market include FMC Corporation, Danone, Abbott Laboratories, Aceto, B. Braun Melsungen AG, Baxter International, BioSig Technologies, Fresenius Kabi AG, Global Health Products, Hansen Medical, Hormel Foods, Mead Johnson Nutrition Company, Meiji Holdings, Nestle S.A., and Victus.

KEY BENEFITS FOR STAKEHOLDERS

This report provides a detailed quantitative analysis of the current market trends and market forecast estimations which helps identify the prevailing oncology nutrition market opportunities.
An in-depth market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global market is provided.
Region-wise and country-wise oncology nutrition market conditions are comprehensively analyzed in this report.
The projections in this report are made by analyzing the current market trends and future market potential in terms of value.
nalysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.An extensive a
Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global oncology nutrition market.

Oncology Nutrition Market Report Highlights

Aspects	Details
By Type	Head & Neck Cancer Stomach & Gastrointestinal Cancers Esophageal Cancer Pancreatic Cancer Liver Cancer Blood Cancer Breast Cancer Lung Cancer Other cancers
By Region	North America (U.S., Canada, Mexico) Europe (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	B. Braun Melsungen AG, BioSig Technologies, Baxter International, Global Health Products, Fresenius Kabi AG, Abbott Laboratories, Hansen Medical, Danone, Aceto, FMC Corporation

CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
  - 1.4.1. Primary Research
  - 1.4.2. Secondary Research
  - 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
  - 3.2.1. Top Investment Pockets
  - 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
  - 3.3.1. Bargaining Power of Suppliers
  - 3.3.2. Threat of New Entrants
  - 3.3.3. Threat of Substitutes
  - 3.3.4. Competitive Rivalry
  - 3.3.5. Bargaining Power among Buyers
- 3.5. Market Dynamics
  - 3.5.1. Drivers
  - 3.5.2. Restraints
  - 3.5.3. Opportunities
- 3.6. COVID-19 Impact Analysis
CHAPTER 4: ONCOLOGY NUTRITION MARKET, BY TYPE
- 4.1. Market Overview
  - 4.1.1 Market Size and Forecast, By Type
- 4.2. Head Neck Cancer
  - 4.2.1. Key Market Trends, Growth Factors and Opportunities
  - 4.2.2. Market Size and Forecast, By Region
  - 4.2.3. Market Share Analysis, By Country
- 4.3. Stomach Gastrointestinal Cancers
  - 4.3.1. Key Market Trends, Growth Factors and Opportunities
  - 4.3.2. Market Size and Forecast, By Region
  - 4.3.3. Market Share Analysis, By Country
- 4.4. Esophageal Cancer
  - 4.4.1. Key Market Trends, Growth Factors and Opportunities
  - 4.4.2. Market Size and Forecast, By Region
  - 4.4.3. Market Share Analysis, By Country
- 4.5. Pancreatic Cancer
  - 4.5.1. Key Market Trends, Growth Factors and Opportunities
  - 4.5.2. Market Size and Forecast, By Region
  - 4.5.3. Market Share Analysis, By Country
- 4.6. Liver Cancer
  - 4.6.1. Key Market Trends, Growth Factors and Opportunities
  - 4.6.2. Market Size and Forecast, By Region
  - 4.6.3. Market Share Analysis, By Country
- 4.7. Blood Cancer
  - 4.7.1. Key Market Trends, Growth Factors and Opportunities
  - 4.7.2. Market Size and Forecast, By Region
  - 4.7.3. Market Share Analysis, By Country
- 4.8. Breast Cancer
  - 4.8.1. Key Market Trends, Growth Factors and Opportunities
  - 4.8.2. Market Size and Forecast, By Region
  - 4.8.3. Market Share Analysis, By Country
- 4.9. Lung Cancer
  - 4.9.1. Key Market Trends, Growth Factors and Opportunities
  - 4.9.2. Market Size and Forecast, By Region
  - 4.9.3. Market Share Analysis, By Country
- 4.10. Other Cancers
  - 4.10.1. Key Market Trends, Growth Factors and Opportunities
  - 4.10.2. Market Size and Forecast, By Region
  - 4.10.3. Market Share Analysis, By Country
CHAPTER 5: ONCOLOGY NUTRITION MARKET, BY REGION
- 5.1. Market Overview
  - 5.1.1 Market Size and Forecast, By Region
- 5.2. North America
  - 5.2.1. Key Market Trends and Opportunities
  - 5.2.2. Market Size and Forecast, By Type
  - 5.2.3. Market Size and Forecast, By Country
  - 5.2.4. U.S. Oncology Nutrition Market
    - 5.2.4.1. Market Size and Forecast, By Type
  - 5.2.5. Canada Oncology Nutrition Market
    - 5.2.5.1. Market Size and Forecast, By Type
  - 5.2.6. Mexico Oncology Nutrition Market
    - 5.2.6.1. Market Size and Forecast, By Type
- 5.3. Europe
  - 5.3.1. Key Market Trends and Opportunities
  - 5.3.2. Market Size and Forecast, By Type
  - 5.3.3. Market Size and Forecast, By Country
  - 5.3.4. France Oncology Nutrition Market
    - 5.3.4.1. Market Size and Forecast, By Type
  - 5.3.5. Germany Oncology Nutrition Market
    - 5.3.5.1. Market Size and Forecast, By Type
  - 5.3.6. Italy Oncology Nutrition Market
    - 5.3.6.1. Market Size and Forecast, By Type
  - 5.3.7. Spain Oncology Nutrition Market
    - 5.3.7.1. Market Size and Forecast, By Type
  - 5.3.8. UK Oncology Nutrition Market
    - 5.3.8.1. Market Size and Forecast, By Type
  - 5.3.9. Russia Oncology Nutrition Market
    - 5.3.9.1. Market Size and Forecast, By Type
  - 5.3.10. Rest Of Europe Oncology Nutrition Market
    - 5.3.10.1. Market Size and Forecast, By Type
- 5.4. Asia-Pacific
  - 5.4.1. Key Market Trends and Opportunities
  - 5.4.2. Market Size and Forecast, By Type
  - 5.4.3. Market Size and Forecast, By Country
  - 5.4.4. China Oncology Nutrition Market
    - 5.4.4.1. Market Size and Forecast, By Type
  - 5.4.5. Japan Oncology Nutrition Market
    - 5.4.5.1. Market Size and Forecast, By Type
  - 5.4.6. India Oncology Nutrition Market
    - 5.4.6.1. Market Size and Forecast, By Type
  - 5.4.7. South Korea Oncology Nutrition Market
    - 5.4.7.1. Market Size and Forecast, By Type
  - 5.4.8. Australia Oncology Nutrition Market
    - 5.4.8.1. Market Size and Forecast, By Type
  - 5.4.9. Thailand Oncology Nutrition Market
    - 5.4.9.1. Market Size and Forecast, By Type
  - 5.4.10. Malaysia Oncology Nutrition Market
    - 5.4.10.1. Market Size and Forecast, By Type
  - 5.4.11. Indonesia Oncology Nutrition Market
    - 5.4.11.1. Market Size and Forecast, By Type
  - 5.4.12. Rest of Asia Pacific Oncology Nutrition Market
    - 5.4.12.1. Market Size and Forecast, By Type
- 5.5. LAMEA
  - 5.5.1. Key Market Trends and Opportunities
  - 5.5.2. Market Size and Forecast, By Type
  - 5.5.3. Market Size and Forecast, By Country
  - 5.5.4. Brazil Oncology Nutrition Market
    - 5.5.4.1. Market Size and Forecast, By Type
  - 5.5.5. South Africa Oncology Nutrition Market
    - 5.5.5.1. Market Size and Forecast, By Type
  - 5.5.6. Saudi Arabia Oncology Nutrition Market
    - 5.5.6.1. Market Size and Forecast, By Type
  - 5.5.7. UAE Oncology Nutrition Market
    - 5.5.7.1. Market Size and Forecast, By Type
  - 5.5.8. Argentina Oncology Nutrition Market
    - 5.5.8.1. Market Size and Forecast, By Type
  - 5.5.9. Rest of LAMEA Oncology Nutrition Market
    - 5.5.9.1. Market Size and Forecast, By Type
CHAPTER 6: COMPETITIVE LANDSCAPE
- 6.1. Introduction
- 6.2. Top Winning Strategies
- 6.3. Product Mapping Of Top 10 Player
- 6.4. Competitive Dashboard
- 6.5. Competitive Heatmap
- 6.6. Top Player Positioning,2022
CHAPTER 7: COMPANY PROFILES
- 7.1. FMC Corporation
  - 7.1.1. Company Overview
  - 7.1.2. Key Executives
  - 7.1.3. Company Snapshot
  - 7.1.4. Operating Business Segments
  - 7.1.5. Product Portfolio
  - 7.1.6. Business Performance
  - 7.1.7. Key Strategic Moves and Developments
- 7.2. Danone
  - 7.2.1. Company Overview
  - 7.2.2. Key Executives
  - 7.2.3. Company Snapshot
  - 7.2.4. Operating Business Segments
  - 7.2.5. Product Portfolio
  - 7.2.6. Business Performance
  - 7.2.7. Key Strategic Moves and Developments
- 7.3. Abbott Laboratories
  - 7.3.1. Company Overview
  - 7.3.2. Key Executives
  - 7.3.3. Company Snapshot
  - 7.3.4. Operating Business Segments
  - 7.3.5. Product Portfolio
  - 7.3.6. Business Performance
  - 7.3.7. Key Strategic Moves and Developments
- 7.4. Aceto
  - 7.4.1. Company Overview
  - 7.4.2. Key Executives
  - 7.4.3. Company Snapshot
  - 7.4.4. Operating Business Segments
  - 7.4.5. Product Portfolio
  - 7.4.6. Business Performance
  - 7.4.7. Key Strategic Moves and Developments
- 7.5. B. Braun Melsungen AG
  - 7.5.1. Company Overview
  - 7.5.2. Key Executives
  - 7.5.3. Company Snapshot
  - 7.5.4. Operating Business Segments
  - 7.5.5. Product Portfolio
  - 7.5.6. Business Performance
  - 7.5.7. Key Strategic Moves and Developments
- 7.6. Baxter International
  - 7.6.1. Company Overview
  - 7.6.2. Key Executives
  - 7.6.3. Company Snapshot
  - 7.6.4. Operating Business Segments
  - 7.6.5. Product Portfolio
  - 7.6.6. Business Performance
  - 7.6.7. Key Strategic Moves and Developments
- 7.7. BioSig Technologies
  - 7.7.1. Company Overview
  - 7.7.2. Key Executives
  - 7.7.3. Company Snapshot
  - 7.7.4. Operating Business Segments
  - 7.7.5. Product Portfolio
  - 7.7.6. Business Performance
  - 7.7.7. Key Strategic Moves and Developments
- 7.8. Fresenius Kabi AG
  - 7.8.1. Company Overview
  - 7.8.2. Key Executives
  - 7.8.3. Company Snapshot
  - 7.8.4. Operating Business Segments
  - 7.8.5. Product Portfolio
  - 7.8.6. Business Performance
  - 7.8.7. Key Strategic Moves and Developments
- 7.9. Global Health Products
  - 7.9.1. Company Overview
  - 7.9.2. Key Executives
  - 7.9.3. Company Snapshot
  - 7.9.4. Operating Business Segments
  - 7.9.5. Product Portfolio
  - 7.9.6. Business Performance
  - 7.9.7. Key Strategic Moves and Developments
- 7.10. Hansen Medical
  - 7.10.1. Company Overview
  - 7.10.2. Key Executives
  - 7.10.3. Company Snapshot
  - 7.10.4. Operating Business Segments
  - 7.10.5. Product Portfolio
  - 7.10.6. Business Performance
  - 7.10.7. Key Strategic Moves and Developments

LIST OF TABLES
TABLE 1. GLOBAL ONCOLOGY NUTRITION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 2. GLOBAL ONCOLOGY NUTRITION MARKET FOR HEAD NECK CANCER, BY REGION, 2022-2032 ($MILLION)
TABLE 3. GLOBAL ONCOLOGY NUTRITION MARKET FOR STOMACH GASTROINTESTINAL CANCERS, BY REGION, 2022-2032 ($MILLION)
TABLE 4. GLOBAL ONCOLOGY NUTRITION MARKET FOR ESOPHAGEAL CANCER, BY REGION, 2022-2032 ($MILLION)
TABLE 5. GLOBAL ONCOLOGY NUTRITION MARKET FOR PANCREATIC CANCER, BY REGION, 2022-2032 ($MILLION)
TABLE 6. GLOBAL ONCOLOGY NUTRITION MARKET FOR LIVER CANCER, BY REGION, 2022-2032 ($MILLION)
TABLE 7. GLOBAL ONCOLOGY NUTRITION MARKET FOR BLOOD CANCER, BY REGION, 2022-2032 ($MILLION)
TABLE 8. GLOBAL ONCOLOGY NUTRITION MARKET FOR BREAST CANCER, BY REGION, 2022-2032 ($MILLION)
TABLE 9. GLOBAL ONCOLOGY NUTRITION MARKET FOR LUNG CANCER, BY REGION, 2022-2032 ($MILLION)
TABLE 10. GLOBAL ONCOLOGY NUTRITION MARKET FOR OTHER CANCERS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL ONCOLOGY NUTRITION MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 12. NORTH AMERICA ONCOLOGY NUTRITION, BY REGION, 2022-2032 ($MILLION)
TABLE 13. NORTH AMERICA ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 14. U.S. ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 15. CANADA ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 16. MEXICO ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 17. EUROPE ONCOLOGY NUTRITION, BY REGION, 2022-2032 ($MILLION)
TABLE 18. EUROPE ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 19. FRANCE ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 20. GERMANY ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 21. ITALY ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 22. SPAIN ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 23. UK ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 24. RUSSIA ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 25. REST OF EUROPE ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 26. ASIA-PACIFIC ONCOLOGY NUTRITION, BY REGION, 2022-2032 ($MILLION)
TABLE 27. ASIA-PACIFIC ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 28. CHINA ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 29. JAPAN ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 30. INDIA ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 31. SOUTH KOREA ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 32. AUSTRALIA ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 33. THAILAND ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 34. MALAYSIA ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 35. INDONESIA ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 36. REST OF ASIA PACIFIC ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 37. LAMEA ONCOLOGY NUTRITION, BY REGION, 2022-2032 ($MILLION)
TABLE 38. LAMEA ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 39. BRAZIL ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 40. SOUTH AFRICA ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 41. SAUDI ARABIA ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 42. UAE ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 43. ARGENTINA ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 44. REST OF LAMEA ONCOLOGY NUTRITION, BY TYPE, 2022-2032 ($MILLION)
TABLE 45. FMC CORPORATION: KEY EXECUTIVES
TABLE 46. FMC CORPORATION: COMPANY SNAPSHOT
TABLE 47. FMC CORPORATION: OPERATING SEGMENTS
TABLE 48. FMC CORPORATION: PRODUCT PORTFOLIO
TABLE 49. FMC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 50. DANONE: KEY EXECUTIVES
TABLE 51. DANONE: COMPANY SNAPSHOT
TABLE 52. DANONE: OPERATING SEGMENTS
TABLE 53. DANONE: PRODUCT PORTFOLIO
TABLE 54. DANONE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 55. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 56. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 57. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 58. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 59. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 60. ACETO: KEY EXECUTIVES
TABLE 61. ACETO: COMPANY SNAPSHOT
TABLE 62. ACETO: OPERATING SEGMENTS
TABLE 63. ACETO: PRODUCT PORTFOLIO
TABLE 64. ACETO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 65. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
TABLE 66. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 67. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 68. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 69. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 70. BAXTER INTERNATIONAL: KEY EXECUTIVES
TABLE 71. BAXTER INTERNATIONAL: COMPANY SNAPSHOT
TABLE 72. BAXTER INTERNATIONAL: OPERATING SEGMENTS
TABLE 73. BAXTER INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 74. BAXTER INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 75. BIOSIG TECHNOLOGIES: KEY EXECUTIVES
TABLE 76. BIOSIG TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 77. BIOSIG TECHNOLOGIES: OPERATING SEGMENTS
TABLE 78. BIOSIG TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 79. BIOSIG TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 80. FRESENIUS KABI AG: KEY EXECUTIVES
TABLE 81. FRESENIUS KABI AG: COMPANY SNAPSHOT
TABLE 82. FRESENIUS KABI AG: OPERATING SEGMENTS
TABLE 83. FRESENIUS KABI AG: PRODUCT PORTFOLIO
TABLE 84. FRESENIUS KABI AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 85. GLOBAL HEALTH PRODUCTS: KEY EXECUTIVES
TABLE 86. GLOBAL HEALTH PRODUCTS: COMPANY SNAPSHOT
TABLE 87. GLOBAL HEALTH PRODUCTS: OPERATING SEGMENTS
TABLE 88. GLOBAL HEALTH PRODUCTS: PRODUCT PORTFOLIO
TABLE 89. GLOBAL HEALTH PRODUCTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 90. HANSEN MEDICAL: KEY EXECUTIVES
TABLE 91. HANSEN MEDICAL: COMPANY SNAPSHOT
TABLE 92. HANSEN MEDICAL: OPERATING SEGMENTS
TABLE 93. HANSEN MEDICAL: PRODUCT PORTFOLIO
TABLE 94. HANSEN MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES
FIGURE 1. GLOBAL ONCOLOGY NUTRITION MARKET SEGMENTATION
FIGURE 2. GLOBAL ONCOLOGY NUTRITION MARKET
FIGURE 3. SEGMENTATION ONCOLOGY NUTRITION MARKET
FIGURE 4. TOP INVESTMENT POCKET IN ONCOLOGY NUTRITION MARKET
FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
FIGURE 8. LOW THREAT OF SUBSTITUTION
FIGURE 9. HIGH COMPETITIVE RIVALRY
FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALONCOLOGY NUTRITION MARKET
FIGURE 11. ONCOLOGY NUTRITION MARKET SEGMENTATION, BY BY TYPE
FIGURE 12. ONCOLOGY NUTRITION MARKET FOR HEAD NECK CANCER, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 13. ONCOLOGY NUTRITION MARKET FOR STOMACH GASTROINTESTINAL CANCERS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 14. ONCOLOGY NUTRITION MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 15. ONCOLOGY NUTRITION MARKET FOR PANCREATIC CANCER, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 16. ONCOLOGY NUTRITION MARKET FOR LIVER CANCER, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 17. ONCOLOGY NUTRITION MARKET FOR BLOOD CANCER, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 18. ONCOLOGY NUTRITION MARKET FOR BREAST CANCER, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 19. ONCOLOGY NUTRITION MARKET FOR LUNG CANCER, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 20. ONCOLOGY NUTRITION MARKET FOR OTHER CANCERS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 25. COMPETITIVE DASHBOARD
FIGURE 26. COMPETITIVE HEATMAP: ONCOLOGY NUTRITION MARKET
FIGURE 27. Top player positioning, 2022
FIGURE 28. FMC CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 29. FMC CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 30. FMC CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 31. DANONE: NET SALES, 2020-2022 ($MILLION)
FIGURE 32. DANONE: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 33. DANONE: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 34. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
FIGURE 35. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 36. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 37. ACETO: NET SALES, 2020-2022 ($MILLION)
FIGURE 38. ACETO: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 39. ACETO: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 40. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 41. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 42. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 43. BAXTER INTERNATIONAL: NET SALES, 2020-2022 ($MILLION)
FIGURE 44. BAXTER INTERNATIONAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 45. BAXTER INTERNATIONAL: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 46. BIOSIG TECHNOLOGIES: NET SALES, 2020-2022 ($MILLION)
FIGURE 47. BIOSIG TECHNOLOGIES: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 48. BIOSIG TECHNOLOGIES: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 49. FRESENIUS KABI AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 50. FRESENIUS KABI AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 51. FRESENIUS KABI AG: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 52. GLOBAL HEALTH PRODUCTS: NET SALES, 2020-2022 ($MILLION)
FIGURE 53. GLOBAL HEALTH PRODUCTS: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 54. GLOBAL HEALTH PRODUCTS: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 55. HANSEN MEDICAL: NET SALES, 2020-2022 ($MILLION)
FIGURE 56. HANSEN MEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 57. HANSEN MEDICAL: REVENUE SHARE, BY REGION, 2032 (%)

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

U.S.-Canada Toll-free: +1-800-792-5285
Int'l :	+1-503-894-6022
Europe :	+44-845-528-1300
Email :	help@alliedmarketresearch.com

Life Sciences	Construction & Manufacturing	Semiconductor & Electronics
Consumer Goods	Food & Beverages	Automotive & Tarnsportation
Materials & Chemicals	Energy & Power	ICT & Media
Aerospace & Defense	BFSI
You must check at least one industry.

Your Shopping Cart Is Empty

Continue Shopping

Oncology Nutrition Market Global Opportunity Analysis and Industry Forecast, 2023-2032

2023

Oncology Nutrition Market

Oncology Nutrition Market

by Type (Head Neck Cancer, Stomach Gastrointestinal Cancers, Esophageal Cancer, Pancreatic Cancer, Liver Cancer, Blood Cancer, Breast Cancer, Lung Cancer, Other cancers): Global Opportunity Analysis and Industry Forecast, 2023-2032

COVID-19

CHAPTER 1: INTRODUCTION

1.1. Report Description

1.2. Key Market Segments

1.3. Key Benefits

1.4. Research Methodology

1.4.1. Primary Research

1.4.2. Secondary Research

1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope

3.2. Key Findings

3.2.1. Top Investment Pockets

3.2.2. Top Winning Strategies

3.3. Porter's Five Forces Analysis

3.3.1. Bargaining Power of Suppliers

3.3.2. Threat of New Entrants

3.3.3. Threat of Substitutes

3.3.4. Competitive Rivalry

3.3.5. Bargaining Power among Buyers

3.5. Market Dynamics

3.5.1. Drivers

3.5.2. Restraints

3.5.3. Opportunities

3.6. COVID-19 Impact Analysis

CHAPTER 4: ONCOLOGY NUTRITION MARKET, BY TYPE

4.1. Market Overview

4.1.1 Market Size and Forecast, By Type

4.2. Head Neck Cancer

4.2.1. Key Market Trends, Growth Factors and Opportunities

4.2.2. Market Size and Forecast, By Region

4.2.3. Market Share Analysis, By Country

4.3. Stomach Gastrointestinal Cancers

4.3.1. Key Market Trends, Growth Factors and Opportunities

4.3.2. Market Size and Forecast, By Region

4.3.3. Market Share Analysis, By Country

4.4. Esophageal Cancer

4.4.1. Key Market Trends, Growth Factors and Opportunities

4.4.2. Market Size and Forecast, By Region

4.4.3. Market Share Analysis, By Country

4.5. Pancreatic Cancer

4.5.1. Key Market Trends, Growth Factors and Opportunities

4.5.2. Market Size and Forecast, By Region

4.5.3. Market Share Analysis, By Country

4.6. Liver Cancer

4.6.1. Key Market Trends, Growth Factors and Opportunities

4.6.2. Market Size and Forecast, By Region

4.6.3. Market Share Analysis, By Country

4.7. Blood Cancer

4.7.1. Key Market Trends, Growth Factors and Opportunities

4.7.2. Market Size and Forecast, By Region

4.7.3. Market Share Analysis, By Country

4.8. Breast Cancer

4.8.1. Key Market Trends, Growth Factors and Opportunities

4.8.2. Market Size and Forecast, By Region

4.8.3. Market Share Analysis, By Country

4.9. Lung Cancer

4.9.1. Key Market Trends, Growth Factors and Opportunities

4.9.2. Market Size and Forecast, By Region

4.9.3. Market Share Analysis, By Country

4.10. Other Cancers

4.10.1. Key Market Trends, Growth Factors and Opportunities

4.10.2. Market Size and Forecast, By Region

4.10.3. Market Share Analysis, By Country

CHAPTER 5: ONCOLOGY NUTRITION MARKET, BY REGION

5.1. Market Overview

5.1.1 Market Size and Forecast, By Region

5.2. North America

5.2.1. Key Market Trends and Opportunities

5.2.2. Market Size and Forecast, By Type

5.2.3. Market Size and Forecast, By Country

Oncology Nutrition Market
Global Opportunity Analysis and Industry Forecast, 2023-2032